Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Percutaneous Transluminal Mitral Commissurotomy in Pregnant Women with Severe Mitral Stenosis.

Firouzi A, Samiei N, Ahmadi S, Naderi N, Sadeghipour P, Sanati HR, Kashfi F, Sattarzadeh R, Hantoushzadeh S, Bayat M, Pourtaghi S, Nasiri M.

J Tehran Heart Cent. 2019 Jan;14(1):12-17.

2.

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease.

Parikh NR, Huiza C, Patel JS, Tsai S, Kalpage N, Thein M, Pitcher S, Lee SP, Inouye WS, Jordan ML, Sanati H, Jafari L, Bennett CJ, Gin GE, Kishan AU, Reiter RE, Lewis M, Sadeghi A, Aronson WJ, Garraway IP, Rettig MB, Nickols NG.

BMC Cancer. 2019 Apr 1;19(1):291. doi: 10.1186/s12885-019-5496-5.

3.

Value of pathologic Q wave in surface electrocardiography in the prediction of myocardial nonviability: A cardiac magnetic resonance imaging-based study.

Arjmand A, Eshraghi A, Sani ZA, Firouzi A, Sanati HR, Nezami H, Jalalyazdi M, Ghiasi SS.

J Adv Pharm Technol Res. 2018 Oct-Dec;9(4):162-164. doi: 10.4103/japtr.JAPTR_345_18.

4.

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention.

Firouzi A, Kazem Moussavi A, Mohebbi A, Alemzadeh-Ansari MJ, Kiani R, Sanati HR, Mohebbi B, Shakerian F, Zahedmehr A, Ansari-Ramandi MM, Oni Heris S, Ghaleshi B, Ghorbani F.

J Cardiovasc Thorac Res. 2018;10(3):149-152. doi: 10.15171/jcvtr.2018.24. Epub 2018 Sep 24.

5.

Effect of flaxseed consumption on flow-mediated dilation and inflammatory biomarkers in patients with coronary artery disease: a randomized controlled trial.

Khandouzi N, Zahedmehr A, Mohammadzadeh A, Sanati HR, Nasrollahzadeh J.

Eur J Clin Nutr. 2019 Feb;73(2):258-265. doi: 10.1038/s41430-018-0268-x. Epub 2018 Aug 20.

PMID:
30127374
6.

Correction to: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention.

Mahdieh N, Rabbani A, Firouzi A, Zahedmehr A, Hoseinimoghaddam M, Saedi S, Sanati H, Basiri H, Noohi F, Rabbani B, Maleki M.

Cardiovasc Toxicol. 2018 Oct;18(5):492. doi: 10.1007/s12012-018-9475-x.

PMID:
30094619
7.

Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention.

Mahdieh N, Rabbani A, Firouzi A, Zahedmehr A, Hoseinimoghaddam M, Saedi S, Sanati H, Basiri H, Noohi F, Rabbani B, Maleki M.

Cardiovasc Toxicol. 2018 Oct;18(5):482-491. doi: 10.1007/s12012-018-9459-x. Erratum in: Cardiovasc Toxicol. 2018 Aug 9;:.

PMID:
29777510
8.

The frequency and importance of chest pain in midterm follow up of transcatheter closure of interatrial septal defect.

Alizadehasl A, Neshati Pir Borj M, Sadeghpour A, Firouzi A, Sanati H, Movassaghi M.

J Cardiovasc Thorac Res. 2017;9(4):215-220. doi: 10.15171/jcvtr.2017.37. Epub 2017 Dec 25.

9.

Metas-Chip precisely identifies presence of micrometastasis in live biopsy samples by label free approach.

Nikshoar MS, Khayamian MA, Ansaryan S, Sanati H, Gharooni M, Farahmand L, Rezakhanloo F, Majidzadeh-A K, Hoseinpour P, Dadgari S, Kiani-M L, Saqafi M, Gity M, Abdolahad M.

Nat Commun. 2017 Dec 19;8(1):2175. doi: 10.1038/s41467-017-02184-x.

10.

Extremely low frequency magnetic field enhances glucose oxidase expression in Pichia pastoris GS115.

Madjid Ansari A, Majidzadeh-A K, Darvishi B, Sanati H, Farahmand L, Norouzian D.

Enzyme Microb Technol. 2017 Mar;98:67-75. doi: 10.1016/j.enzmictec.2016.12.011. Epub 2017 Jan 3.

PMID:
28110666
11.

Mitral valve resistance determines hemodynamic consequences of severe rheumatic mitral stenosis and immediate outcomes of percutaneous valvuloplasty.

Sanati H, Zolfaghari R, Samiei N, Rezaei Y, Chitsazan M, Zahedmehr A, Shakerian F, Kiani R, Firouzi A, Rezaei Tabrizi R.

Echocardiography. 2017 Feb;34(2):162-168. doi: 10.1111/echo.13448. Epub 2017 Jan 10.

PMID:
28070915
12.

Intracoronary versus Intravenous eptifibatide during percutaneous coronary intervention for acute ST-segment elevation myocardial infarction; a randomized controlled trial.

Sanati HR, Zahedmehr A, Firouzi A, Farrashi M, Amin K, Peighambari MM, Shakerian F, Kiani R.

Cardiovasc Interv Ther. 2017 Oct;32(4):351-357. doi: 10.1007/s12928-016-0418-9. Epub 2016 Aug 17.

PMID:
27534402
13.

Self-Expandable Stent for Repairing Coarctation of the Left-Circumferential Aortic Arch with Right-sided Descending Aorta and Aberrant Right Subclavian Artery with Kommerell's Aneurysm.

Khajali Z, Sanati HR, Pouraliakbar H, Mohebbi B, Aeinfar K, Zolfaghari R.

Ann Vasc Surg. 2017 Jan;38:318.e7-318.e10. doi: 10.1016/j.avsg.2016.05.116. Epub 2016 Aug 12.

PMID:
27531082
14.

Acute Myocardial Infarction Following Blunt Chest Trauma and Coronary Artery Dissection.

Abdolrahimi SA, Sanati HR, Ansari-Ramandi MM, Heris SO, Maadani M.

J Clin Diagn Res. 2016 Jun;10(6):OD14-5. doi: 10.7860/JCDR/2016/19043.7994. Epub 2016 Jun 1.

15.

In-hospital and six-month outcomes of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.

Noohi F, Hashemi I, Sanati HR, Peighambari MM, Kiavar M, Maadani M, Bassiri HA, Zahedmehr A, Shakerian F, Firouzi A, Kiani R, Abdi S.

ARYA Atheroscler. 2016 Jan;12(1):28-34.

16.

The Effects of Side Branch Predilation During Provisional Stenting of Coronary Bifurcation Lesions: A Double-Blind Randomized Controlled Trial.

Peighambari M, Sanati H, Hadjikarimi M, Zahedmehr A, Shakerian F, Firouzi A, Kiani R, Sadeghipour P, Kzaemi Asl S.

Res Cardiovasc Med. 2016 Mar 5;5(2):e31378. doi: 10.5812/cardiovascmed.31378. eCollection 2016 May.

17.

Coronary Slow Flow Phenomenon Clinical Findings and Predictors.

Sanati H, Kiani R, Shakerian F, Firouzi A, Zahedmehr A, Peighambari M, Shokrian L, Ashrafi P.

Res Cardiovasc Med. 2016 Jan 2;5(1):e30296. doi: 10.5812/cardiovascmed.30296. eCollection 2016 Feb.

18.

Comparison of outcomes of diseased coronary arteries ectasia, stenosis and combined.

Shakerian F, Sanati H, Kiani R, Khezerlou N, Firouzi A, Zahedmehr A.

Res Cardiovasc Med. 2015 Jan 20;4(1):e25206. doi: 10.5812/cardiovascmed.25206. eCollection 2015 Feb.

19.

Antiproliferative effects of copper(II)-polypyridyl complexes in breast cancer cells through inducing apoptosis.

Salimi M, Abdi K, Kandelous HM, Hadadzadeh H, Azadmanesh K, Amanzadeh A, Sanati H.

Biometals. 2015 Apr;28(2):267-78. doi: 10.1007/s10534-015-9820-5. Epub 2015 Feb 12.

PMID:
25673217
20.

Effect of garlic powder tablet on carotid intima-media thickness in patients with coronary artery disease: a preliminary randomized controlled trial.

Mahdavi-Roshan M, Zahedmehr A, Mohammad-Zadeh A, Sanati HR, Shakerian F, Firouzi A, Kiani R, Nasrollahzadeh J.

Nutr Health. 2013 Apr;22(2):143-55. doi: 10.1177/0260106014563446. Epub 2015 Jan 8.

PMID:
25573347
21.

Evaluation of Percutaneous Coronary Intervention and stenting of Left Main Coronary Artery Stenosis in Tehran's Rajaie and Lavasani Hospitals from 2010 to 2011.

Abdolrahimi S, Sanati H, Fatahian A.

Res Cardiovasc Med. 2013 Nov;2(4):181-4. doi: 10.5812/cardiovascmed.12594. Epub 2013 Oct 28.

22.

Pre-procedural Serum Lipid Profile and Post-procedural Myocardial Injury.

Sanati H.

Res Cardiovasc Med. 2013 Nov;2(4):174-5. doi: 10.5812/cardiovascmed.14739. Epub 2013 Oct 28. No abstract available.

23.

Intravenous magnesium sulfate: new method in prevention of contrast-induced nephropathy in primary percutaneous coronary intervention.

Firouzi A, Maadani M, Kiani R, Shakerian F, Sanati HR, Zahedmehr A, Nabavi S, Heidarali M.

Int Urol Nephrol. 2015 Mar;47(3):521-5. doi: 10.1007/s11255-014-0890-z. Epub 2014 Dec 5.

PMID:
25475196
24.

Association of polymorphisms at LDLR locus with coronary artery disease independently from lipid profile.

Jamaldini SH, Babanejad M, Mozaffari R, Nikzat N, Jalalvand K, Badiei A, Sanati H, Shakerian F, Afshari M, Kahrizi K, Najmabadi H.

Acta Med Iran. 2014;52(5):352-9.

25.

In vitro Therapeutic Effects of Low Level Laser at mRNA Level on the Release of Skin Growth Factors from Fibroblasts in Diabetic Mice.

Khoo NK, Shokrgozar MA, Kashani IR, Amanzadeh A, Mostafavi E, Sanati H, Habibi L, Talebi S, Abouzaripour M, Akrami SM.

Avicenna J Med Biotechnol. 2014 Apr;6(2):113-8.

26.

Anti-proliferative and apoptotic activities of constituents of chloroform extract of Juglans regia leaves.

Salimi M, Ardestaniyan MH, Mostafapour Kandelous H, Saeidnia S, Gohari AR, Amanzadeh A, Sanati H, Sepahdar Z, Ghorbani S, Salimi M.

Cell Prolif. 2014 Apr;47(2):172-9. doi: 10.1111/cpr.12090. Epub 2014 Jan 27.

PMID:
24467376
27.

Risk Factors of Reperfusion Failure following Primary Angioplasty for ST-Segment Elevation Myocardial Infarction (STEMI).

Sanati HR, Mahjoob MP, Zahedmehr A, Ghahferokhi FS, Firoozi A, Kiani R, Sadeghi Z, Diz AA, Abkenar HB.

J Tehran Heart Cent. 2013 Jul;8(3):146-51. Epub 2013 Jul 30.

28.

Diagnostic value of electrocardiography compared with echocardiography in measuring left ventricular mass index in major thalassemia patients over 10 years of age.

Noori N, Mahjoubifard M, Alavi SM, Hosseini S, Sanati H, Mirmesdagh Y.

J Tehran Heart Cent. 2013 Jul;8(3):121-6. Epub 2013 Jul 30.

29.

Difficult management of coronary artery disease in a patient with thrombotic thrombocytopenic purpura.

Jorfi F, Sanati HR, Zahedmehr A, Shakerian F, Zahedi L, Firouzi A, Kiani R, Elmi G.

J Tehran Heart Cent. 2014;9(3):140-2. Epub 2014 Jul 3.

30.

Near-complete pathological response with preoperative chemotherapy in a patient with metaplastic breast carcinoma.

Amini A, Kakkis J, Reitherman R, Ibarra J, Sanati H.

Anticancer Drugs. 2013 Aug;24(7):765-8. doi: 10.1097/CAD.0b013e328362d78c.

PMID:
23719538
31.

Intracoronary adenosine to prevent myonecrosis in patients with stable angina undergoing percutaneous interventions: a double-blinded randomized controlled trial.

Sanati HR, Ghanavati R, Zahedmehr A, Shakerian F, Bakhshandeh H, Firouzi A, Kiani R.

J Tehran Heart Cent. 2013 Jan;8(1):28-34. Epub 2013 Jan 8.

32.

Coronary Flow Assessment in Unstable Angina/non ST-segment Elevation Myocardial Infarction Patients via Thrombolysis in Myocardial Infarction Frame Count in Angiography.

Sanati H, Zahedmehr A, Firouzi A, Salehi N, Maadani M, Shakerian F, Kiani R, Golnari P, Parchami-Ghazaee S, Peighambari M.

Res Cardiovasc Med. 2013 May;2(2):95-8. doi: 10.5812/cardiovascmed.9087. Epub 2013 May 20.

33.

Application of the health belief model in promotion of self-care in heart failure patients.

Baghianimoghadam MH, Shogafard G, Sanati HR, Baghianimoghadam B, Mazloomy SS, Askarshahi M.

Acta Med Iran. 2013;51(1):52-8.

34.

Impella 2.5 in a patient with left main coronary artery occlusion.

Sanati HR, Amin A, Shakerian F, Abdi S, Hosseini S, Potapov EV.

J Cardiol Cases. 2013 Mar 5;7(5):e142-e144. doi: 10.1016/j.jccase.2013.01.002. eCollection 2013 May.

35.

Percutaneous device closure for secundum-type atrial septal defect: short and intermediate-term results.

Abdi S, Kiani R, Momtahen M, Basiri HA, Maadani M, Abdolrahimi S, Firozi I, Sanati H, Shakerian F, Firoozi A, Salehi N, Zahedmehr A.

Arch Iran Med. 2012 Nov;15(11):693-5. doi: 0121511/AIM.009.

36.

Healing potential of mesenchymal stem cells cultured on a collagen-based scaffold for skin regeneration.

Shokrgozar MA, Fattahi M, Bonakdar S, Ragerdi Kashani I, Majidi M, Haghighipour N, Bayati V, Sanati H, Saeedi SN.

Iran Biomed J. 2012;16(2):68-76.

37.

Percutaneous mitral valvuloplasty using echocardiographic intercommissural diameter as reference for balloon sizing: a randomized controlled trial.

Sanati HR, Zahedmehr A, Shakerian F, Bakhshandeh H, Firoozi A, Kiani R, Sadeghpour A, Asgharnedjad E, Mikaelpour A, Nabati M.

Clin Cardiol. 2012 Dec;35(12):749-54. doi: 10.1002/clc.22013. Epub 2012 Jun 6.

38.

Immediate results of percutaneous trans-luminal mitral commissurotomy in pregnant women with severe mitral stenosis.

Abdi S, Salehi N, Ghodsi B, Basiri HA, Momtahen M, Firouzi A, Sanati HR, Shakerian F, Maadani M, Bakhshandeh H, Chamanian S, Chitsazan M, Vakili-Zarch A.

Clin Med Insights Cardiol. 2012;6:35-9. doi: 10.4137/CMC.S8580. Epub 2012 Feb 9.

39.

Comparison of the clinical and morphologic characteristics of culprit lesions in unstable angina and non-ST-elevation myocardial infarction.

Kiani R, Sanati HR, Abdi S, Shakerian F, Firoozi A, Zahedmehr A.

Heart Asia. 2012 Jan 1;4(1):32-6. doi: 10.1136/heartasia-2011-010047. eCollection 2012.

40.

Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients.

Firouzi A, Eshraghi A, Shakerian F, Sanati HR, Salehi N, Zahedmehr A, Kiani R, Madani M, Pedarzadeh A.

Int Urol Nephrol. 2012 Aug;44(4):1145-9. doi: 10.1007/s11255-011-0053-4. Epub 2011 Sep 7.

PMID:
21898040
41.

Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.

Amini A, Sanati H.

Anticancer Drugs. 2011 Nov;22(10):1024-6. doi: 10.1097/CAD.0b013e32834a2c16.

PMID:
21822120
42.

Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing.

Alizadeh A, Sanati HR, Haji-Karimi M, Yazdi AH, Rad MA, Haghjoo M, Emkanjoo Z.

Europace. 2011 Nov;13(11):1587-90. doi: 10.1093/europace/eur198. Epub 2011 Jul 8.

PMID:
21742681
43.

relationship between distribution of coronary artery lesions and renal artery stenosis in patients undergoing simultaneous coronary and renal angiography.

Salehi N, Firouzi A, Gholoobi A, Shakerian F, Sanati HR, Ahmadabadi MN, Moradi M.

Clin Med Insights Cardiol. 2011 Mar 20;5:35-40. doi: 10.4137/CMC.S6819.

44.

Percutaneous mitral valvuloplasty--a new method for balloon sizing based on maximal commissural diameter to improve procedural results.

Sanati HR, Kiavar M, Salehi N, Shakerian F, Firoozi A, Parsa SA, Behzadnia N, Bakhshandeh H, Peighambari MM, Maleki M.

Am Heart Hosp J. 2010 Summer;8(1):29-32.

PMID:
21194046
45.

Quality measures for supportive cancer care: the Cancer Quality-ASSIST Project.

Lorenz KA, Dy SM, Naeim A, Walling AM, Sanati H, Smith P, Shanman R, Roth CP, Asch SM.

J Pain Symptom Manage. 2009 Jun;37(6):943-64. doi: 10.1016/j.jpainsymman.2008.05.018. Epub 2009 Apr 8.

PMID:
19359135
46.

Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer.

Raj KP, Sanati H, Mehta RS, Zell JA.

Anticancer Drugs. 2009 Apr;20(4):301-4. doi: 10.1097/CAD.0b013e328329707c.

PMID:
19247177
47.

Evidence-based recommendations for cancer nausea and vomiting.

Naeim A, Dy SM, Lorenz KA, Sanati H, Walling A, Asch SM.

J Clin Oncol. 2008 Aug 10;26(23):3903-10. doi: 10.1200/JCO.2007.15.9533. Review.

PMID:
18688059
48.

Evidence-based recommendations for information and care planning in cancer care.

Walling A, Lorenz KA, Dy SM, Naeim A, Sanati H, Asch SM, Wenger NS.

J Clin Oncol. 2008 Aug 10;26(23):3896-902. doi: 10.1200/JCO.2007.15.9509. Review.

PMID:
18688058
49.

Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea.

Dy SM, Lorenz KA, Naeim A, Sanati H, Walling A, Asch SM.

J Clin Oncol. 2008 Aug 10;26(23):3886-95. doi: 10.1200/JCO.2007.15.9525. Review.

PMID:
18688057
50.

Evidence-based standards for cancer pain management.

Dy SM, Asch SM, Naeim A, Sanati H, Walling A, Lorenz KA.

J Clin Oncol. 2008 Aug 10;26(23):3879-85. doi: 10.1200/JCO.2007.15.9517. Review.

PMID:
18688056

Supplemental Content

Loading ...
Support Center